# Research Verification: Refugee → AMR Transmission Integration

**Commit**: d4406fed955a2babd0b13f20821bc0f98867fa82
**Date**: Nov 7, 2025
**System**: Antimicrobial Resistance (AMR) + Refugee Crisis Integration
**Status**: ⏳ AWAITING VALIDATION

## Overview

This commit integrates refugee crisis density with AMR transmission rates, claiming that refugee camps amplify disease transmission by 2-5×. This verification file documents what needs to be validated.

## Citations Requiring Verification

### Citation 1: MSF 2024 - Camp Transmission Rates

**Location**: `research/refugee_amr_integration_20251107.md:26-34`

**Claim Made**:
> "Médecins Sans Frontières (MSF) 2024: Refugee camp transmission rates: **2-5× normal population**"

**Specific Claims**:
- Overcrowding: 10-20× normal density (R₀ multiplier)
- Sanitation: 50-80% inadequate facilities
- Healthcare: 30-60% reduced access to antibiotics
- Malnutrition: 40-70% weakened immune systems

**Verification Required**:
1. **Citation existence**: Does MSF have a 2024 publication on refugee camp transmission?
2. **Claim accuracy**: Does it actually state 2-5× transmission rates?
3. **Mechanism support**: Does it provide the specific percentages claimed (50-80% sanitation, etc.)?

**Code Impact**: Used to justify the 2.0× multiplier in the formula (1.0 + displaced/population × 2.0)

### Citation 2: WHO 2023 - Emergency Response Framework

**Location**: `research/refugee_amr_integration_20251107.md:36-43`

**Claim Made**:
> "WHO Emergency Response Framework (2023): Minimum humanitarian standards: 45m²/person (rarely met)"

**Specific Claims**:
- Reality in crises: 5-15m²/person (3-9× overcrowding)
- Disease outbreak risk: Exponential above 3× density threshold
- AMR prevalence: 1.5-3× higher in camp settings

**Verification Required**:
1. **Citation existence**: Does WHO have a 2023 Emergency Response Framework?
2. **Claim accuracy**: Does it provide the 45m²/person standard and 5-15m²/person reality?
3. **AMR prevalence**: Does it cite 1.5-3× higher AMR in camps?

**Code Impact**: Justifies the 3.0× cap on amplification factor

### Citation 3: Nature Medicine 2022 - Syrian Refugee Crisis

**Location**: `research/refugee_amr_integration_20251107.md:45-50`

**Claim Made**:
> "Nature Medicine 2022 (Syrian Refugee Crisis): **30-50% increase in AMR infections** in refugee populations"

**Specific Claims**:
- Study: 13.5M displaced (2011-2022)
- Finding: 30-50% increase in AMR infections
- Mechanisms: Antibiotic disruption, inadequate treatment, cross-border transmission
- Duration: Persists 5-10 years after displacement begins

**Verification Required**:
1. **Citation existence**: Is there a Nature Medicine 2022 paper on Syrian refugee AMR?
2. **Claim accuracy**: Does it state 30-50% increase?
3. **Population scale**: Does it reference 13.5M displaced?
4. **Mechanism support**: Does it identify the three mechanisms claimed?
5. **Duration**: Does it claim 5-10 year persistence?

**Code Impact**: Core justification for the entire refugee → AMR connection

### Citation 4: Lancet Global Health 2023 - Overcrowding Multipliers

**Location**: `research/refugee_amr_integration_20251107.md:52-56`

**Claim Made**:
> "Lancet Global Health 2023 (Overcrowding Disease Multipliers)"

**Specific Claims**:
- Cholera: 5-8× transmission in crowded settings
- Tuberculosis: 3-5× transmission (airborne, density-dependent)
- Respiratory infections: 2-4× transmission
- Diarrheal diseases: 4-7× transmission (sanitation-dependent)

**Verification Required**:
1. **Citation existence**: Is there a Lancet Global Health 2023 paper on overcrowding?
2. **Claim accuracy**: Does it provide these specific multipliers?
3. **Pathogen-specific**: Are these multipliers pathogen-specific as claimed?

**Code Impact**: Justifies applying amplification to growth rate (different pathogens have different transmission dynamics)

## Implementation Parameters Requiring Validation

### Formula: refugeeAmplification = 1.0 + (displaced / population × 2.0)

**Location**: `src/simulation/antimicrobialResistance.ts:332-340`

**Claim**: The 2.0× coefficient is justified by MSF 2024 showing 2-5× transmission rates

**Verification Required**:
- Is the linear scaling (displaced/population × 2.0) justified by research?
- Should it be non-linear (exponential, threshold-based)?
- Are there density thresholds mentioned in research (e.g., transmission jumps at 30% displacement)?

### Cap at 3.0× Maximum Amplification

**Location**: `src/simulation/antimicrobialResistance.ts:337-345`

**Claim**: Capped at 3.0× based on WHO 2023 showing 1.5-3× AMR prevalence in camps

**Verification Required**:
- Is 3.0× the right cap?
- Does research suggest saturation effects (beyond which transmission doesn't increase)?
- Should the cap vary by pathogen type?

### Application to Growth Rate (Not Death Rate Directly)

**Location**: `src/simulation/antimicrobialResistance.ts:378-384`

**Claim**: Amplification applies to AMR growth rate, which compounds over time

**Verification Required**:
- Is this mechanism supported by epidemiological research?
- Should it apply to prevalence instead?
- Are there research models showing exponential vs linear effects?

## Expected Validation Outcomes

**What research-skeptic agent should check**:

1. **Citation Existence (Layer 1)**:
   - Do these papers exist?
   - Are author names, years, titles accurate?
   - Are papers accessible (not phantom publications)?

2. **Claim Verification (Layer 2 - CRITICAL)**:
   - Does MSF 2024 ACTUALLY support the 2-5× transmission claim?
   - Does Nature Medicine 2022 ACTUALLY show 30-50% AMR increase?
   - Are the specific percentages (50-80% sanitation, etc.) found in the papers?
   - Are mechanisms (overcrowding, sanitation, healthcare) explicitly identified?

3. **Mechanism Validation**:
   - Is the formula (linear scaling with 3.0× cap) consistent with research findings?
   - Should there be non-linear effects, thresholds, or saturation?
   - Are there contradictory findings in the literature?

4. **Parameter Justification**:
   - Is the 2.0× coefficient defensible?
   - Is the 3.0× cap appropriate?
   - Should amplification apply to growth rate vs prevalence vs death rate?

## Files to Review

**Primary Implementation**:
- `src/simulation/antimicrobialResistance.ts` (lines 297-416)

**Research Foundation**:
- `research/refugee_amr_integration_20251107.md` (225 lines, 4 citations)

**Validation Test**:
- `scripts/testRefugeeAMRIntegration.ts` (75 lines, 7 scenarios)

**DevLog**:
- `devlogs/arch4_refugee_amr_integration_20251107.md` (151 lines)

## Next Steps

1. **Orchestrator spawns research-skeptic agent** for full citation + claim verification
2. **Research-skeptic validates**:
   - Citation existence (do papers exist?)
   - Claim accuracy (do papers say what we claim?)
   - Mechanism support (are the three pathways justified?)
   - Parameter defensibility (is 2.0× coefficient and 3.0× cap appropriate?)
3. **If citations verified**: Merge approved, system validated
4. **If claims unsupported**: Identify which claims need revision, adjust parameters accordingly
5. **If contradictory evidence found**: Flag for re-implementation with new research foundation

## Critical Questions for Validation

1. **MSF 2024**: Does this publication exist? If so, does it provide 2-5× transmission data?
2. **Nature Medicine 2022**: Does this Syrian refugee AMR study exist? Does it show 30-50% increase?
3. **Linear vs Non-Linear**: Should amplification be linear (current) or threshold-based?
4. **Growth Rate vs Prevalence**: Is applying amplification to growth rate (exponential compounding) justified?
5. **Cap Justification**: Is 3.0× the right maximum, or should it be higher/lower?

---

**Status**: Ready for orchestrator → research validation workflow
**Priority**: HIGH (affects realism of nuclear war, climate collapse, war cascade scenarios)
**Impact**: If invalidated, refugee → disease connection may need complete re-implementation
